Healthcare >> CEO Interviews >> September 13, 2002
MADS KROGSGAARD THOMSEN is Executive Vice President and Chief Science
Officer (CSO) of Novo Nordisk A/S. He joined Novo Nordisk in 1991 as
head of Pharmacology, Biopharmaceuticals Division. In 1993 he became
director of Pharmacology, Diabetes R&D, Diabetes Care Division, and
later the same year was appointed Senior Vice President, Diabetes R&D,
Diabetes Care Division. He was appointed Corporate Vice President,
Health Care Discovery and Preclinical Development, in 1995. Prior to
joining Novo Nordisk, Mr. Thomsen worked as a post-graduate scholar from
1986 to 1987 at the Royal Veterinary and Agricultural University of
Copenhagen. From 1988 to 1991 he worked for Leo Pharmaceutical Products.
Mr. Thomsen holds a Doctor of Veterinary Medicine degree from the Royal
Veterinary and Agricultural University of Copenhagen (1986), where he
also obtained the PhD degree in 1989 and the DSc degree in 1991 and in
June 2000 became professor of pharmacology. Mr. Thomsen is frequently
sought as an invited speaker and chairman at international meetings and
symposia, sits on editorial boards of three international journals and
has published a substantial number of scientific papers in a number of
international journals. Mr. Thomsen is a member of the board of
directors of the Danish Technical University. Profile
company, would you mention a few highlights in its history and then give
us an overview of the current state of
